EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

PDE4 Inhibitors: Profiling Hits through the Multitude of Structural Classes

Jian Jin, Francesca Mazzacuva, Letizia Crocetti iD, Maria Paola Giovannoni, Agostino Cilibrizzi iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241411518 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Jian Jin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical Science, King's College London, Stamford Street, London SE1 9NH, UK. Hauptthemen laut MEDLINE: Phosphodiesterase 4 Inhibitors, Asthma, Pulmonary Disease, Chronic Obstructive, Psoriasis. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cyclic nucleotide phosphodiesterases 4 (PDE4) are a family of enzymes which specifically promote the hydrolysis and degradation of cAMP. The inhibition of PDE4 enzymes has been widely investigated as a possible alternative strategy for the treatment of a variety of respiratory diseases, including chronic obstructive pulmonary disease and asthma, as well as psoriasis and other autoimmune disorders. In this context, the identification of new molecules as PDE4 inhibitors continues to be an active field of investigation within drug discovery. This review summarizes the medicinal chemistry journey in the design and development of effective PDE4 inhibitors, analyzed through chemical classes and taking into consideration structural aspects and binding properties, as well as inhibitory efficacy, PDE4 selectivity and the potential as therapeutic agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Phosphodiesterase 4 InhibitorsAsthmaPulmonary Disease, Chronic ObstructivePsoriasisHumans3',5'-Cyclic-AMP PhosphodiesterasesCyclic Nucleotide Phosphodiesterases, Type 4

Stichwörter der Autor:innen

PDE4 inhibitorsPDE4 selectivitydual activityphosphodiesterases 4respiratory diseasesstructural analysis

Substanzen

Phosphodiesterase 4 Inhibitors3',5'-Cyclic-AMP PhosphodiesterasesCyclic Nucleotide Phosphodiesterases, Type 4

Autor:innen und Institutionen

  • Institute of Pharmaceutical Science, King's College London, Stamford Street, London SE1 9NH, UK.
  • School of Health, Sport and Bioscience, University of East London, London E15 4LZ, UK.
  • Neurofarba Department, Pharmaceutical and Nutraceutical Section, Via Ugo Schiff 6, Sesto Fiorentino, University of Florence, 50019 Florence, Italy.
  • Centre for Therapeutic Innovation, University of Bath, Bath BA2 7AY, UK.

ORCID-Profile: Letizia Crocetti, Agostino Cilibrizzi

Zitieren

APA

Jin, J., Mazzacuva, F., Crocetti, L., Giovannoni, M. P., & Cilibrizzi, A. (2023). PDE4 Inhibitors: Profiling Hits through the Multitude of Structural Classes. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241411518

Vancouver

Jin J, Mazzacuva F, Crocetti L, Giovannoni MP, Cilibrizzi A. PDE4 Inhibitors: Profiling Hits through the Multitude of Structural Classes. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241411518

BibTeX
@article{Jin2023,
  author = {Jin, Jian and Mazzacuva, Francesca and Crocetti, Letizia and Giovannoni, Maria Paola and Cilibrizzi, Agostino},
  title = {PDE4 Inhibitors: Profiling Hits through the Multitude of Structural Classes},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241411518}
}
Kostenlos starten →